Diploma PLC reported revenue results for the first quarter ended December 31, 2022. For the quarter, the company reported Organic revenue growth 10%: broad-based momentum in Controls, sustained strong growth at Seals and Life Sciences on track for sustainable growth as surgical procedures continue to recover. Reported revenue growth 30%: 11% contribution from high quality acquisitions and a 9% foreign exchange benefit.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,276 GBX | -1.47% | +2.25% | +19.37% |
05-14 | RBC Boosts Diploma PT, Affirms Sector Perform Rating | MT |
05-14 | Berenberg Lifts Diploma PT, Keeps Buy Recommendation | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+19.37% | 7.45B | |
+8.06% | 40.08B | |
+20.87% | 8.06B | |
-16.04% | 4.77B | |
+16.56% | 1.62B | |
+4.40% | 1.54B | |
+27.39% | 1.54B | |
+31.15% | 1.23B | |
-1.80% | 1.02B | |
+53.59% | 841M |
- Stock Market
- Equities
- DPLM Stock
- News Diploma PLC
- Diploma PLC Reports Revenue Results for the First Quarter Ended December 31, 2022